Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Mechanism of action: Activates both GLP-1 receptors AND GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously GIP receptors in fat tissue directly regulate lipid metabolism and fat cell energy storage Dual activation creates a synergistic effect on appetite suppression and energy expenditure Produces stronger improvement in insulin sensitivity compared to GLP-1-only medications FDA-approved brand names: Zepbound approved for chronic weight management Mounjaro approved for type 2 diabetes Why does the dual mechanism matter
It originated as part of Lilly's program to extend the dual-agonist concept proven by tirzepatide into a triple-agonist class, and it is the first such molecule to advance into Phase 3 in any indication [1][3][4]
Gallbladder issues May develop in patients with rapid weight loss
Hospitals and clinics often provide similar services
A healthcare practitioner can provide the necessary guidance and support throughout the supplementation process
US$ 25.80
US$ 22.54
US$ 27.89
US$ 21.97
US$ 21.05
US$ 29.60
US$ 21.09
US$ 21.84
US$ 28.52
US$ 26.50
